Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

ClinicalTrials.gov ID: NCT04247074

Public ClinicalTrials.gov record NCT04247074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Study identification

NCT ID
NCT04247074
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Galderma R&D
Industry
Enrollment
413 participants

Conditions and interventions

Interventions

  • botulinum toxin neuromodulator Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 9, 2020
Primary completion
Oct 1, 2020
Completion
Feb 25, 2021
Last update posted
Sep 5, 2023

2020 – 2021

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
11
Facility City State ZIP Site status
Clinical Testing of Beverly Hills Encino California 91436
Ava MD Santa Monica California 90404
Skin Care & Laser Physicians of Beverly Hills West Hollywood California 90069
Center for Clinical and Cosmetic Research Aventura Florida 33180
Baumann Cosmetic & Research Institute, Inc Miami Florida 33137
Washington Institute of Dermatologic Laser Surgery Chevy Chase Maryland 20815
Maryland Dermatology, Laser, Skin & Vein Institute Hunt Valley Maryland 21030
Skin Specialists, PC Omaha Nebraska 68144
Lorenc Aesthetic Plastic Surgery Center New York New York 10028
Elite Aesthetic Research Cincinnati Ohio 45236
The Westlake Dermatology Clinical Research Austin Texas 78746

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04247074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 5, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04247074 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →